FR2413353A1 - L'acetyl salicylate de n-methyl glucamine, nouveau derive hydrosoluble - Google Patents

L'acetyl salicylate de n-methyl glucamine, nouveau derive hydrosoluble

Info

Publication number
FR2413353A1
FR2413353A1 FR7739740A FR7739740A FR2413353A1 FR 2413353 A1 FR2413353 A1 FR 2413353A1 FR 7739740 A FR7739740 A FR 7739740A FR 7739740 A FR7739740 A FR 7739740A FR 2413353 A1 FR2413353 A1 FR 2413353A1
Authority
FR
France
Prior art keywords
acetyl
esp
salicylate
intramuscular injection
glucamine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7739740A
Other languages
English (en)
Other versions
FR2413353B1 (fr
Inventor
Silvano Casadio
Henri Cousse
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pierre Fabre SA
Original Assignee
Pierre Fabre SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pierre Fabre SA filed Critical Pierre Fabre SA
Priority to FR7739740A priority Critical patent/FR2413353A1/fr
Publication of FR2413353A1 publication Critical patent/FR2413353A1/fr
Application granted granted Critical
Publication of FR2413353B1 publication Critical patent/FR2413353B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/76—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring
    • C07C69/84—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring of monocyclic hydroxy carboxylic acids, the hydroxy groups and the carboxyl groups of which are bound to carbon atoms of a six-membered aromatic ring
    • C07C69/90—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring of monocyclic hydroxy carboxylic acids, the hydroxy groups and the carboxyl groups of which are bound to carbon atoms of a six-membered aromatic ring with esterified hydroxyl and carboxyl groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

L'INVENTION CONCERNE UN NOUVEAU COMPOSE CHIMIQUE UTILE COMME MEDICAMENT ET DES COMPOSITIONS PHARMACEUTIQUES. LE NOUVEAU COMPOSE CHIMIQUE REPOND A LA FORMULE: (CF DESSIN DANS BOPI) LES MEDICAMENTS CONTENANT CE PRINCIPE ACTIF SONT UTILES DANS LE TRAITEMENT D'HYPERTHERMIES ET ALGIES DIVERSES.
FR7739740A 1977-12-27 1977-12-27 L'acetyl salicylate de n-methyl glucamine, nouveau derive hydrosoluble Granted FR2413353A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR7739740A FR2413353A1 (fr) 1977-12-27 1977-12-27 L'acetyl salicylate de n-methyl glucamine, nouveau derive hydrosoluble

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7739740A FR2413353A1 (fr) 1977-12-27 1977-12-27 L'acetyl salicylate de n-methyl glucamine, nouveau derive hydrosoluble

Publications (2)

Publication Number Publication Date
FR2413353A1 true FR2413353A1 (fr) 1979-07-27
FR2413353B1 FR2413353B1 (fr) 1980-08-22

Family

ID=9199518

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7739740A Granted FR2413353A1 (fr) 1977-12-27 1977-12-27 L'acetyl salicylate de n-methyl glucamine, nouveau derive hydrosoluble

Country Status (1)

Country Link
FR (1) FR2413353A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4501727A (en) * 1981-12-08 1985-02-26 The Boots Company Plc Therapeutic agent

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4501727A (en) * 1981-12-08 1985-02-26 The Boots Company Plc Therapeutic agent

Also Published As

Publication number Publication date
FR2413353B1 (fr) 1980-08-22

Similar Documents

Publication Publication Date Title
DE3170684D1 (en) An orally administered drug form comprising a polar bioactive agent and an adjuvant
AR218037A1 (es) Procedimiento para preparar un sistema terapeutico en la forma de un parche cutaneo para la administracion de la droga clonidina
SE7514589L (sv) Aminosyrapreparat for patienter med leversjukdom och sett att anvenda dessa preparat
ES2038135T3 (es) Medios para la administracion de acido hialuronico en mamiferos.
ATE108657T1 (de) Galanthemin enthaltende pharmazeutische formulierung zur behandlung des alkoholismus.
DK0563023T3 (da) Anvendelse af vævsfaktor pathway inhibitor til fremstilling af et medikament til anvendelse ved en fremgangsmåde til hæmnin
NO158678C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive vicinale dihydroksyalkyl-xantiner.
SE9002500D0 (sv) Farmaceutisk, nac-innehaallande komposition foer oral administrering
MX7557E (es) Procedimiento para la preparacion de proteoglicanos purificados y destoxificados solubles en agua
SE7413548L (fr)
US3489793A (en) New benzamido butyric acid derivatives
FR2413353A1 (fr) L'acetyl salicylate de n-methyl glucamine, nouveau derive hydrosoluble
ES2123004T3 (es) Uso de factor de crecimiento derivado de plaquetas en la preparacion de un medicamento para el tratamiento de ulceras gastrointestinales.
JPS5753413A (en) Adjuvant for conducting drug substance to rectum
ES2044848T3 (es) Empleo de extractos de petasita para preparar un medicamento para el tratamiento de enfermedades gastrointestinales.
DK0398217T3 (da) Dehydrocholecalciferolderivater
JPS51146432A (en) Process for preparation of benzanilide derivatives having therapeutic action to immunological disease
SE7613090L (sv) Pikolinsyraderivat och forfarande for framstellning derav
Guth et al. Prostaglandin cytoprotection does not involve interference with aspirin absorption
FR2276818A1 (fr) Bestatine, ses sels d'addition d'acides et esters et leur application pharmacologique
FR2319346A1 (fr) Medicament comprenant une association d'un agent anti-inflammatoire et d'un imidazole ou d'un benzimidazole
US4189499A (en) Lysine 4-allyloxy-3-chlorophenylacetate and method of its preparation
FR2343484A1 (fr) Le 2- (2-acetamido-2-deoxy-3-o-d-glucopyranosyl) -d-propionyl-l-alanyl-d- (a-methylamide)-glutamique et medicaments le contenant
EP0637448A1 (fr) Combinaisons de la glycinamide ou de la N-acétylglycinamide avec des composés analgésique
FI863192A0 (fi) Preparat foer intramuskulaer injektering av mediciner, vitaminer eller vaccin.

Legal Events

Date Code Title Description
ST Notification of lapse